SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001354488-16-006289
Filing Date
2016-02-18
Accepted
2016-02-18 16:30:32
Documents
2
Period of Report
2015-09-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 3  
1 PRIMARY DOCUMENT primary_doc.xml 3 1551
2 POWER OF ATTORNEY ex241.htm EX-24 7543
  Complete submission text file 0001354488-16-006289.txt   10836
Mailing Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560
Business Address ONE COPLEY PARKWAY SUITE 490 MORRISVILLE NC 27560 919-806-4414
TENAX THERAPEUTICS, INC. (Issuer) CIK: 0000034956 (see all company filings)

IRS No.: 262593535 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research

Mailing Address C/O NEPHROGENEX, INC. 79 T.W. ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address
Mitchum James P. (Reporting) CIK: 0001597439 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-34600 | Film No.: 161438410